Campbell & CO Investment Adviser LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2022$418,000
-24.0%
10,086
+33.1%
0.10%
-35.8%
Q1 2022$550,000
+67.7%
7,580
+94.4%
0.15%
+32.1%
Q4 2021$328,000
+11.9%
3,900
+20.0%
0.11%
+17.9%
Q3 2021$293,000
+20.6%
3,250
+27.5%
0.10%
-5.0%
Q2 2021$243,000
-40.7%
2,550
-29.2%
0.10%
-60.3%
Q1 2021$410,000
-27.7%
3,600
-72.8%
0.25%
+17.8%
Q3 2019$567,000
+34.0%
13,244
+50.7%
0.21%
-48.7%
Q4 2018$423,0008,7900.42%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2021
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$4,658,0002.63%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,364,434$84,745,0001.21%
CAPITAL INTERNATIONAL LTD /CA/ 259,700$16,130,0001.07%
Aureus Asset Management, LLC 65,670$4,079,0000.69%
Capital International Sarl 124,320$7,722,0000.67%
CAPITAL GUARDIAN TRUST CO 512,430$31,827,0000.58%
ROCKEFELLER FINANCIAL SERVICES INC 408,379$25,365,0000.50%
Rock Springs Capital Management LP 160,500$9,969,0000.50%
Hood River Capital Management LLC 112,296$6,975,0000.48%
Capital International, Inc./CA/ 52,700$3,273,0000.47%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders